Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tioconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 5/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 5/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 5/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 5/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 4/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 4/20 | 1.00 |
| ▸ | CYP17A1 | P05093 | 4/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 4/20 | 1.00 |
| ▸ | DRD2 | P14416 | 4/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 4/20 | 1.00 |
| ▸ | DRD3 | P35462 | 4/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 3/20 | 1.00 |
| ▸ | HTR2A | P28223 | 3/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 3/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 3/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 3/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tioconazole SCHEMBL29882046 | 1.00 | PGR (1.00) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL41355 | 1.00 | PGR (1.00) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL3682100 | 1.00 | PGR (1.00) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL29881791 | 1.00 | PGR (1.00) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL3682098 | 1.00 | PGR (1.00) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL29408808 | 1.00 | PGR (1.00) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL3722115 | 0.99 | PGR (0.98) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL7165886 | 0.99 | PGR (0.98) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL7165888 | 0.99 | PGR (0.98) | PGRADORA3SLC6A2SLC6A4SLC6A3 | |
| Tioconazole SCHEMBL9441817 | 0.95 | PGR (0.91) | PGRADORA3SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16571 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719384-A2 | COMPOUNDS WITH ANTIFUNGAL PROPERTIES | Trustees of Dartmouth College (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260076924-A1 | COMPOSITIONS AND METHODS OF TREATMENT FOR TINEA PEDIS | THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260027255-A1 | Cross-Linked Telechelic Polymer Compositions, Methods of Preparation Thereof, and Methods of Using Same | BETTY YU SKIN TECH ADVISORS LLC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4680240-A1 | METHOD OF TREATING DISORDERS WITH SURF1 MALFUNCTION | Cure Mito Foundation (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260007753-A1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2026-01-08 | — | — | US | claimed |
| WO-1987002580-A1 | FILM-FORMING, PHARMACEUTICAL VEHICLES FOR APPLICATION OF MEDICAMENTS TO NAILS, PHARMACEUTICAL COMPOSITIONS BASED ON THOSE VEHICLES, AND METHODS OF USING SAME | DERMATOLOGICAL PRODUCTS OF TEXAS (US) | 1987-05-07 | — | — | WO | claimed |
| US-4661493-A | ECONAZOLE, CLOTRIMAZOLE, KETOCONAZOLE, BUTACONAZOLE | PFIZER INC. (US) | 1987-04-28 | — | — | US | claimed |
| WO-1987002219-A1 | ALPHA TOCOPHEROL-BASED VESICLES | THE LIPOSOME COMPANY, INC. (US) | 1987-04-23 | — | — | WO | claimed |
| WO-1986005977-A1 | STEROIDAL LIPOSOMES | THE LIPOSOME COMPANY, INC. (US) | 1986-10-23 | — | — | WO | claimed |
| EP-0196855-A2 | Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections | PFIZER INC. (US) | 1986-10-08 | — | — | EP | claimed |
| EP-0064830-B1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NAIL INFECTIONS | Pfizer Limited (GB) | 1986-02-26 | — | — | EP | claimed |
| EP-0165783-A1 | Aromatase inhibiting N-substitued imidazole derivatives | ELI LILLY AND COMPANY (US) | 1985-12-27 | — | — | EP | claimed |
| EP-0064830-A2 | Pharmaceutical compositions for treating nail infections | Pfizer Limited (GB) | 1982-11-17 | — | — | EP | claimed |
| US-4277475-A | FOR BOTH MALES AND FEMALES | SYNTEX (U.S.A.) INC. (US) | 1981-07-07 | — | — | US | claimed |
| US-4247552-A | Contraceptive compositions and methods employing 1-substituted imidazole derivatives | SYNTEX (U.S.A.) INC. (US) | 1981-01-27 | — | — | US | claimed |